Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.7%

2 terminated out of 26 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

15%

4 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (7)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed14
Unknown5
Recruiting2
Not Yet Recruiting2
Terminated2
Enrolling By Invitation1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT07527182Not ApplicableCompleted

Artemisinin Partial Resistance in Ethiopian Plasmodium Falciparum: A Multisite Clinical, Molecular and In Vitro Study

NCT04990596CompletedPrimary

Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)

NCT07071103Phase 2Recruiting

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors

NCT07203846Phase 4Not Yet Recruiting

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

NCT07082465Not Yet RecruitingPrimary

Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand

NCT07073755Recruiting

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

NCT06037564Phase 4Enrolling By Invitation

B-free Multistage Trial

NCT04833231Completed

The Relationship Between Renal Functions and Multi Drug Resistant Organisms

NCT05310370Unknown

HRD and Resistance to PAPPi in EOC Patients

NCT04326868Phase 4Completed

Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in Gabon

NCT04516395Not ApplicableUnknownPrimary

Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae

NCT04404582CompletedPrimary

Clinical Characteristics for the Critical Ill Patients With Klebsiella Pneumoniae Infection

NCT02401204Completed

Bacterial Transmission Dynamics Study

NCT03114098Not ApplicableCompletedPrimary

Pharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic Drugs

NCT01386476CompletedPrimary

(18F)FCWAY and the Blood-Brain Barrier

NCT03401957Unknown

The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment

NCT03361267Not ApplicableUnknown

Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection

NCT02792816CompletedPrimary

Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar

NCT00965042Phase 1Completed

Effect of Ceftobiprole on Human Intestinal Microflora

NCT01039480CompletedPrimary

Aspirin and Clopidogrel Resistance Study

Scroll to load more

Research Network

Activity Timeline